Two-Day Conference Draws Cardiac Electrophysiology Experts From Across the Globe
AUSTIN, Texas, March 2, 2016 /PRNewswire/ -- On March 3 and 4, 2016, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its third international symposium on complex arrhythmias, EP Live 2016. EP Live is an intensive, two-day educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex arrhythmias, a condition in which the heart beats with an irregular or abnormal rhythm. The primary teaching tool is live cases broadcast from the state-of-the-art laboratories at St. David's Medical Center, with expert commentary.
"This year, we're expecting nearly 150 leaders in the field of electrophysiology from Europe, Asia and Latin America, as well as experts from across the United States," Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI and EP Live course director, said. "Over the years, advances in interventional cardiac electrophysiology have impacted physician practices and patient care. This event is a way for physicians to come together to learn the full scope of EP procedures, ultimately improving patient care across the globe."
Arrhythmias are caused by problems with the heart's electrical system. Many cardiac arrhythmias are treated using modern ablation procedures, which involve burning, freezing or neutralizing portions of the heart muscle where abnormal electrical pulses set off the irregular heartbeats. EP Live is designed to help attendees gain a better understanding of techniques used to treat atrial and ventricular arrhythmias, implant complex devices and extract malfunctioning devices.
EP Live consists of four sections: Atrial Fibrillation (AF) ablation, Ventricular Tachycardia (VT) ablation, Devices and New Technologies. The sessions consist of a combination of live and recorded cases from some of the premier centers of the world: TCAI, Mayo Clinic, Stanford University Medical Center, Mount Sinai Hospital, UCLA Health System, the University of Pennsylvania Health System, Brigham and Women's Hospital, Loyola University, Chicago Stritch School of Medicine, Lancaster General Hospital and Massachusetts General Hospital.
Cases include procedures to treat endocardial and epicardial VT ablation, AF ablation, AF Rotors and post-AF arrhythmias; balloon cases; Cardiac Resynchronization Therapy implants; lead extraction and venoplasty.
EP Live will also feature new technologies, including the latest generation of the EpiAccess(TM) System to access the pericardial cavity of the heart during an epicardial ablation.
The conference will also focus on a variety of objectives, including:
-- Evaluating techniques used to map and ablate atrial and ventricular
-- Identifying processes to reduce complications and promote safety
measures for the patient during ablation of AF and ventricular
-- Applying interventional approaches learned in ablation of complex
-- Demonstrating an understanding of the latest evidence and guidelines in
arrhythmia management and treatment with new technology; and
-- Applying interventional approaches that best utilize the new
technologies demonstrated to maximize clinical outcomes.
In addition to demonstrations by Dr. Natale, EP Live will feature presentations by a number of TCAI physicians, including course co-director, Amin Al-Ahmad, M.D., as well as Rodney Horton, M.D.; Patrick Hranitzky, M.D.; Robert Canby, M.D.; Joseph Gallinghouse, M.D.; Shane Bailey, M.D.; Javier Sanchez, M.D.; David Burkhardt, M.D. and Jason Zagrodsky, M.D.
Physicians will receive a maximum of 16 American Medical Association (AMA) Physician's Recognition Award (PRA) Category 1 Credit((TM)) hours at the conference.
The Texas Cardiac Arrhythmia Institute at St. David's Medical Center (TCAI) is one of the world's preeminent centers dedicated to the latest treatment advances for correcting arrhythmias. The center is led by Dr. Natale, who is at the forefront of advancing treatment for A Fib, leading numerous clinical trials, and participating in the development of new technologies and procedures.
For more information, visit EPLiveSymposium.com [http://www.eplivesymposium.com/].
Erin Ochoa and Kristin Marcum
Elizabeth Christian Public Relations
Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center